ag-01
mAbexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02816827)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Sortilin/ProgranulinINHIBITOR
Sortilin/Progranulin inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ag-01
- ag-01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05627960 | Phase 1 | Feb 14, 2022 | A&G Pharmaceutical Inc., University of Maryland |
| NCT02816827 | N/A | Mar 1, 2016 | Enovate Biolife Pvt Ltd, Vedic Lifesciences Pvt. Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| A&G Pharmaceutical Inc. | For profit | 1 | 1 | 1 | 2022 |
| Enovate Biolife Pvt Ltd | For profit | 1 | 0 | 1 | 2016 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Vedic Lifesciences Pvt. Ltd. | For profit | 1 | 1 | 1 | 2016 |
4 organizations
Page 1 / 1